Super Settlement Spike
Setbacks, perhaps coupled with jury research that may have suggested that a huge verdict against Moderna was possible, clearly contributed.
Setbacks, perhaps coupled with jury research that may have suggested that a huge verdict against Moderna was possible, clearly contributed.
The decline of trial practice opportunities for litigators of all experience levels is something that should be concerning to all of us.
Put away the guesswork—Lexis® Verdict & Settlement Analyzer helps legal professionals assess case potential with confidence by using data-driven insights from the industry’s largest collection of verdicts and settlements.
The importance of teamwork in driving successful litigation results can’t be overstated -- especially in complex IP litigation.
The patent litigation market is ever-changing.
Khurram Naik was a major contributor to one of the IP success stories of 2025.
Having a diversified and considered approach to marketing is the best way to spotlight your practice’s unique market offerings.
Drawing on more than a decade of data, the report equips law firms and corporate legal teams with actionable insights to better assess risk, refine strategy, and anticipate outcomes in today’s evolving workplace disputes.
Both pragmatism and resilience are essential to success in legal practice.
The surge in law school applications promises to make the 2026 application cycle one of the most competitive ever.
A patent owner’s statements about the scope of its patents must always be considered carefully.
The LF Dealmakers Forum reminds us of the need to stay vigilant, knowledgeable about the rules of the game, and flexible enough to adapt to policy decisions.
Depositions by Filevine help with scheduling, tracking goals, and trial prep.
The current patent litigation funding market is a lot like a cup of coffee.
The confidential nature of the work done by IP attorneys adds complexity to marketing their achievements.
The report’s presentation of data shows that modern patent litigation remains a vibrant and challenging pursuit for both plaintiffs and defendants.
The introduction of Cologuard after FDA-approval in 2014 has been a gamechanger in colon cancer diagnosis.
There is no doubt in my mind that Free Law Project’s tools are a must-add to any aspiring federal court litigator’s toolbox.